LA
Standard BioTools Inc.
LAB · NASDAQ
$0.77 +4.75% (+$0.03)
1M +18.43%
Market Cap $301.3M
P/E Ratio -
Div. Yield -
ROE 18.16%
Piotroski F-Score Weak
3/9Valuation
75 /100
Cheap P/S 3.56x
P/B 0.56x
P/E N/A
Growth
0 /100
Declining Rev. growth 4.49%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 49.14%
Net margin 103.29%
Op. margin 94.80%
Quality
2 /100
Poor ROIC 8.25%
ROE 18.16%
ROA 13.93%
Debt
69 /100
Low Debt/Equity 0.05x
Current ratio 9.10x
Int. coverage -6,591.47x
Stability
42 /100
Moderate Beta 1.37x
Rev. volatility 57.57%
EPS volatility 9.67%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre LAB
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Michael Egholm
Employees
387
Headquarters
Boston
Evenimente viitoare
03 NOV.
Earnings
Upcoming earnings report